Mucus Relief Dm Tablet
NDC Package 11822-0733-2
Package Information
Mucus Relief Dm (guaifenesin, dextromethorphan hbr) tablets is do not crush, chew, or break tablettake with a full glass of water this product can be administered without regards for timing of meals adults and children 12 years of age and older: 1 or 2 tablet every 12 hours; not more than 4 tablets in 24 hourschildren under 12 years of age: do not use . This formulation utilizes a tablet delivery system. Marketed by Rite Aid Corporation, this product is identified by NDC 11822-0733 and is authorized under FDA application ANDA209692.
Identification & Billing
- RxCUI: 1298324 - guaiFENesin 600 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet
- RxCUI: 1298324 - 12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG Extended Release Oral Tablet
- RxCUI: 1298324 - dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG 12 HR Extended Release Oral Tablet
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 11822 - Rite Aid Corporation
- 11822-0733 - Mucus Relief Dm
- 11822-0733-2 - 20 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
- 11822-0733 - Mucus Relief Dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11822-0733). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11822-0733-2 identifies a specific commercial package of 20 blister pack in 1 carton / 1 tablet in 1 blister pack of Mucus Relief Dm, a human over the counter drug labeled by Rite Aid Corporation. This tablet is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rite Aid Corporation on February 28, 2019.
How is this Rite Aid Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11822073302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
